logo
BioCentury to Host Grand Rounds in Chicago: Where Translational Science Meets Investors and Dealmakers

BioCentury to Host Grand Rounds in Chicago: Where Translational Science Meets Investors and Dealmakers

Business Wire14-05-2025
CHICAGO--(BUSINESS WIRE)--Top decision-makers from across the biopharma ecosystem will convene in Chicago for the 2 nd BioCentury Grand Rounds – U.S., at the intersection of research, investment and drug development. Designed to drive practical progress in R&D, the conference connects academic innovators with biopharma executives and early-stage investors who are building the next wave of biotech breakthroughs.
BioCentury is bringing together VCs, biopharma R&D decision-makers and academic innovators to discuss critical bottlenecks in the translation of scientific discoveries into the next wave of biotech breakthroughs. #BioCenturyGrandRounds
Share
Taking place June 4 – 6 at the Four Seasons Hotel Chicago, the program will address critical bottlenecks in three themes:
Disease biology
Therapeutic modalities
Enabling technologies
Featured sessions include a plenary with Marty Burke, Professor of Chemical Innovation at the University of Illinois Urbana-Champaign, and a fireside chat with Jonathon Sedgwick, SVP and Global Head of Discovery Research at AbbVie. In a special Horizon session, Luciana Borio, Venture Partner at ARCH Ventures, will lead a panel on the future of research funding. View the full agenda.
Speakers include R&D, investment and academic leaders from AUTM, Biogen, Chan Zuckerberg Biohub Chicago, Daiichi Sankyo, Deerfield Management, Eli Lilly, Genmab, Johnson & Johnson Innovation, Merck & Co., Northwestern University, Novartis Venture Fund, Takeda, The University of Chicago and many other leaders in the industry.
'At this complex and politically fraught moment, bringing industry and academia together to enable the future of translational research is more critical than ever,' said Simone Fishburn, VP & Editor in Chief of BioCentury. 'BioCentury continues its 30-year tradition of fostering the future of medicine, bringing innovators and investors to delve into the science that can write the next stories in biotech.'
'We are hugely pleased the Chicago Biomedical Consortium and their Midwest colleagues have joined the Grand Rounds community,' said BioCentury Co-Founder and CEO David Flores. 'This important biomedical ecosystem will be a foundational link in the global network BioCentury is building to collectively identify solutions for translating great science into transformational cures.'
Flores added: 'The Grand Rounds network, begun last year with our launch partners Vanderbilt University and Life Science Tennessee, will grow further with our first Grand Rounds - Europe meeting in the U.K. in September, led by Cambridge University Health Partners, Cambridge Innovation Capital and AstraZeneca.'
The importance of Grand Rounds in Chicago is demonstrated by its collaborators. Insights Partner McKinsey & Company is joined by Founding Investors ARCH Venture Partners, Iaso Ventures, Lightspeed Venture Partners, MPM BioImpact, Third Rock Ventures and Xontogeny; and Sponsors Chan Zuckerberg Biohub Chicago, Collaborative Drug Discovery, inThought Research and Xentria.
Regional Hosts advancing innovation in the Midwest include Chicago Biomedical Consortium, iBIO, Northwestern Memorial Healthcare, Northwestern University, P33, Portal Innovations, The University of Chicago, University of Illinois Chicago, and the University of Illinois Urbana-Champaign.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Onsemi posts quarterly revenue drop, sees dull third-quarter profit on market uncertainty
Onsemi posts quarterly revenue drop, sees dull third-quarter profit on market uncertainty

Yahoo

time21 minutes ago

  • Yahoo

Onsemi posts quarterly revenue drop, sees dull third-quarter profit on market uncertainty

(Reuters) -U.S. automotive chipmaker Onsemi on Monday forecast lackluster profit for the third quarter, after reporting a sharp decline in second-quarter revenue, sending its shares down by more than 10%. Sales growth in battery electric vehicles has slowed due to an uncertain economic environment, brought on by global import duties, and elevated borrowing costs in the U.S. Consumers have hit the breaks on big-ticket spending as tariffs threaten to increase the costs of automobiles by thousands of dollars and drive up inflation. This has been forcing automakers to reassess production plans and withhold financial investments, affecting companies such as Onsemi. The company acknowledged during its earnings call that the EV market remains soft, especially in North America and Europe, with recovery being slower than hoped. However, Onsemi said it sees "signs of stabilization" across its end markets, after a prolonged slump in demand due to excess chip supply. The company is among a select group of suppliers providing silicon carbide chips, which are critical for extending the range of EVs. It added that it has not yet seen a broad-based recovery in automotive and expects only low single-digit growth in the third quarter. An end to the $7,500 federal tax credit for electric cars has also cast a cloud over the EV industry's outlook, with some firms expecting a hit to the market growth. Onsemi expects third-quarter adjusted earnings between 54 cents and 64 cents per share, compared with analysts' average estimate of 59 cents, according to data compiled by LSEG. It forecast revenue of $1.47 billion and $1.57 billion for the third quarter, the midpoint of which is slightly above estimates of $1.50 billion. The company's second-quarter revenue of $1.47 billion beat expectations of $1.45 billion, but fell about 15% from a year ago.

Time Finance bolsters funding facilities to more than £250m
Time Finance bolsters funding facilities to more than £250m

Yahoo

time21 minutes ago

  • Yahoo

Time Finance bolsters funding facilities to more than £250m

UK-based specialist lender Time Finance has reported an increase in its lending facilities, surpassing £250m. The expansion is the result of renewed agreements with a consortium of eight funding partners, providing the company with additional financial leeway exceeding £95m. The company aims to extend its reach across the UK, aligning with its strategic plan that spans the next three years, concluding in May 2028. Time Finance CFO James Roberts said: "I am delighted that the group has put in place substantial funding facilities as we embark on our new three-year growth plan. The previous plan, from June 2021 to May 2025, saw invoice finance lending increase by 170% and hard asset lending by 249%. 'Strong demand for both product sets has continued to be experienced in the first months of the new financial year, which began on 1 June 2025. "As such, the significant headroom provided by these larger and more flexible facilities across all lending divisions position the Group well as it looks to further support UK business requiring funding for business-critical equipment through asset finance or working capital solutions through invoice finance." Furthermore, Time Finance announced that it will release its fully audited financial statements for the year ending 31 May 2025 on 24 September. Concurrently, a trading update for the first quarter of fiscal year 2025/26 will be provided. Last month, the company reappointed Tom Ludden as business development manager in its Invoice Finance division to support the company's goal of expanding its own-book lending to £300m. "Time Finance bolsters funding facilities to more than £250m " was originally created and published by Leasing Life, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

Eating fewer ultra-processed foods could boost weight loss, trial suggests
Eating fewer ultra-processed foods could boost weight loss, trial suggests

Yahoo

timean hour ago

  • Yahoo

Eating fewer ultra-processed foods could boost weight loss, trial suggests

Eating minimally processed foods and avoiding ultra processed foods (UPFs) could help people lose twice as much weight, a new trial has found. Sticking to meals cooked from scratch could also help curb food cravings, researchers suggest. UPFs include the likes of processed meals, ice cream, crisps, some breakfast cereals, biscuits and fizzy drinks. They tend to have high levels of saturated fat, salt and sugar, as well as additives and ingredients that are not used when people cook from scratch, like preservatives, emulsifiers and artificial colours and flavours. The trial, led by experts at University College London (UCL) and University College London Hospitals NHS Foundation Trust (UCLH), involved 55 people split into two groups. Half were given an eight-week diet plan comprising minimally processed foods, such as overnight oats and spaghetti bolognese, while the other half were given foods like breakfast oat bars or lasagne ready meals. After completing one diet, the groups then switched. Researchers matched the two diets nutritionally on levels of fat, saturated fat, protein, carbohydrates, salt and fibre using the Eatwell Guide, which outlines recommendations on how to eat a healthy, balanced diet. Dr Samuel Dicken, of the UCL Centre for Obesity Research and UCL department of behavioural science and health, said: 'Previous research has linked ultra-processed foods with poor health outcomes. 'But not all ultra-processed foods are inherently unhealthy based on their nutritional profile.' He said the main aim of the study was to explore the role of food processing and how it impacts weight, blood pressure, body composition and food cravings. Some 50 people completed the trial, with both groups losing weight. However, those on the minimally processed diet lost more weight (2.06%) compared to the UPF diet (1.05% loss). The UPF diet also did not result in significant fat loss, researchers said. Dr Dicken said: 'Though a 2% reduction may not seem very big, that is only over eight weeks and without people trying to actively reduce their intake. 'If we scaled these results up over the course of a year, we'd expect to see a 13% weight reduction in men and a 9% reduction in women on the minimally processed diet, but only a 4% weight reduction in men and 5% in women after the ultra-processed diet. 'Over time this would start to become a big difference.' Those on the trial were also asked to complete questionnaires on food cravings before and after starting the diets. Those eating minimally processed foods had less cravings and were able to resist them better, the study suggests. However, researchers also measured others markers like blood pressure, heart rate, liver function, glucose levels and cholesterol and found no significant negative impacts of the UPF diet. Professor Chris van Tulleken, of the UCL division of infection and immunity and UCLH, said: 'The global food system at the moment drives diet-related poor health and obesity, particularly because of the wide availability of cheap, unhealthy food. 'This study highlights the importance of ultra-processing in driving health outcomes in addition to the role of nutrients like fat, salt and sugar.' The Eatwell Guide recommends the average woman should consume around 2,000 calories a day, while an average man should consume 2,500. Both diet groups had a calorie deficit, meaning people were eating fewer calories than what they were burning, which helps with weight loss. However, the deficit was higher from minimally processed foods at around 230 calories a day, compared with 120 calories per day from UPFs. Professor Rachel Batterham, senior author of the study from the UCL centre for obesity research, said: 'Despite being widely promoted, less than 1% of the UK population follows all of the recommendations in the Eatwell Guide, and most people stick to fewer than half. 'The normal diets of the trial participants tended to be outside national nutritional guidelines and included an above average proportion of UPF, which may help to explain why switching to a trial diet consisting entirely of UPF, but that was nutritionally balanced, resulted in neutral or slightly favourable changes to some secondary health markers. 'The best advice to people would be to stick as closely to nutritional guidelines as they can by moderating overall energy intake, limiting intake of salt, sugar and saturated fat, and prioritising high-fibre foods such as fruits, vegetables, pulses and nuts. 'Choosing less processed options such as whole foods and cooking from scratch, rather than ultra-processed, packaged foods or ready meals, is likely to offer additional benefits in terms of body weight, body composition and overall health.' Commenting on the study, Tracy Parker, nutrition lead at the British Heart Foundation, said: 'These findings support what we have long suspected – that the way food is made might affect our health, not just the nutrients it contains. 'The way this study was designed means it is more reflective of real-world conditions than previous research on ultra-processed foods. 'Unlike earlier observational studies, this was a randomised controlled trial where participants were provided with all their meals, and the diets were carefully matched to meet the Eatwell Guide – this allowed researchers to isolate the effect of food processing itself, making it more likely that the differences seen after eight weeks were due to how the food in their diets was processed, not just what was in it. 'Completely cutting UPFs out of our diets isn't realistic for most of us, but including more minimally processed foods – like fresh or home cooked meals – alongside a balanced diet could offer added benefits too. 'Mediterranean-style diets, which include plenty of minimally or unprocessed foods such as fruit, vegetables, fish, nuts and seeds, beans, lentils and wholegrains, have consistently been shown to reduce our risk of heart attacks and strokes.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store